Anales de investigación clínica y de laboratorio

  • ISSN: 2386-5180
  • Índice h de la revista: 17
  • Puntuación de cita de revista: 6.26
  • Factor de impacto de la revista: 5.31
Indexado en
  • Genamics JournalSeek
  • Infraestructura Nacional de Conocimiento de China (CNKI)
  • CiteFactor
  • Directorio de indexación de revistas de investigación (DRJI)
  • Publón
  • pub europeo
  • Google Académico
  • SHERPA ROMEO
  • Laboratorios secretos de motores de búsqueda
Comparte esta página

Abstracto

Examining the Executives' Proposals to Competitors for Type 1 Diabetes

Bradley Alkabbani*

Competitors with type 1 diabetes (T1D) experience new challenges maintaining optimal glucose levels and as a result need specialised guidance from their medical services providers. In this, we hope to compile and analyse recommendations targeted at T1D the executives in rivals' efficient position articulations and commonly used clinical practise guidelines. The objective is to assess the available proposals under the presumption that they are comprehensive enough for competitors to apply to superior execution sport. Extension of clinical practise guidelines may be possible in order to increase the breadth and depth of proposals for superior execution competitors.

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado